3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Melanoma
4
Lymphoma, Follicular
3
Sarcoma
2
Neoplasms
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Philadelphia Chromosome
1
Multiple Myeloma
1
Meningeal Carcinomatosis
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Kidney Neoplasms
1
Influenza, Human
1
Hepatitis B, Chronic
1
Hepatitis B
1
Heartburn
1
Gastrointestinal Cancer Metastatic
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Brain Neoplasms
1
Blast Crisis
1
Interventions
Imatinib Mesylate
5
Dasatinib
4
Vincristine
3
Methotrexate
3
Dexamethasone
3
Cytarabine
3
peginterferon alfa-2a
2
Prednisone
2
Daunorubicin
2
Cyclophosphamide
2
Azacitidine
2
venetoclax
1
thymoglobulin
1
ponatinib
1
olverembatinib
1
flumatinib
1
fludarabine phosphate
1
fludarabine
1
blinatumomab
1
Whole-Body Irradiation
1
Tyrosine Kinase Inhibitors
1
Tacrolimus
1
Rituximab
1
Prednisolone
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Mycophenolic Acid
1
Mitoxantrone
1
Mercaptopurine
1
Melphalan
1
Interferons
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Philadelphia Chromosome
×
Interferons
×
Clear all
NCT00763763
2011-10-05
AFR07
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
55 enrolled